Brooks Hill Partners Invests in Cake End-of-Life Planning
Brooks Hill Partners has invested in Cake, an end-of-life planning and advanced care decision-making platform.
top of page
_edited_edited.png)
NEWS & EVENTS
Search
- Nov 1, 2020
Brooks Hill Partners Invests in Totient
Brooks Hill Partners has announced an investment in Totient, an AI-driven biotech company focused on tertiary lymphoid structures.
- Sep 24, 2020
CB Insights' Future of Health
CB Insights’ Future of Health will bring together senior executives from the world’s largest healthcare institutions, startups, and more.
- Sep 22, 2020
Rock Health Summit
Rock Health Summit is a two-day digital health conference in San Francisco that brings together diverse minds from medicine and beyond.
- Feb 27, 2020
AI Powered Drug Discovery and Manufacturing Conference
The potential of AI to revolutionize drug discovery and manufacturing has kindled significant research efforts across industry and academia.
- Feb 11, 2020
Panel on How Artificial Intelligence is Transforming Biotech Partnerships & Drug Discovery
A panel of successful entrepreneurs and experts will discuss various topics, ranging from company launch to AI-based strategic partnerships.
- Jan 28, 2020
Key Takeaways from the 2020 J.P. Morgan Healthcare Conference
Never before has the market maintained such an upward trajectory for this long.
- Dec 1, 2019
Brooks Hill Partners invests in Qulab Seed Financing
Brooks Hill Partners announces an investment in the Seed financing of Qulab, a quantum computing company focused on molecular drug design.
- Jan 17, 2019
Brooks Hill Partners Announces Partnership with Solstice Strategy Group
Brooks Hill Partners and the Solstice Strategy Group today announced a digital health strategic partnership.
- Feb 1, 2018
Brooks Hill Partners Invests in Deep 6 AI
Brooks Hill Partners has invested in Deep 6 AI, a company bringing AI technology to clinical trial recruitment.
- Jun 1, 2017
Brooks Hill Partners Joins Round for Reflect
Brooks Hill Partners has announced a new investment in reflect, a teletherapy company providing mental health services built for everyone.
- Apr 1, 2017
Brooks Hill Partners Joins Financing for Astrocyte Pharmaceuticals
Brooks Hill Partners has added Astrocyte Pharmaceuticals, a drug development company focused on brain injuries, to their portfolio.
Interested in learning more?
393 Totten Pond Rd, Unit 404, Waltham MA, 02451 | Email: info@brookshillpartners.com | Tel: 617.903.7699 |
© 2022 by Brooks Hill Partners
bottom of page